Approval · Notice of Compliance 17005 · 2015
FRISIUM: Notice of Compliance 17005
Issued June 16, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17005
- Date
- June 16, 2015
- Company
- Lundbeck Inc
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- General update to the product monograph, including safety update, re-organisation in line with guidance documents and addition of the patient medication information
- Therapeutic class
- Antiepileptic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FRISIUM | Not yet assigned | — |
Medicinal ingredients
- CLOBAZAM 10 MG per TAB